IMCR Insider Trading Activity and SEC Form 4 Filings
IMCR insider trading summary
Over the past 12 months, insiders at Immunocore Holdings plc (IMCR) reported 10 sales worth $5.6M by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $5.6M.
Latest IMCR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 18, 2026 | Bahija Jallal | Chief Executive Officer | Sell | $371K (11,474 @ $32.35) |
| Feb 18, 2026 | Leger Tina Amber St | Chief Hr Officer | Sell | $32K (1,000 @ $32.35) |
| Feb 18, 2026 | David M Berman | Head of R&D | Sell | $193K (5,965 @ $32.35) |
| Feb 18, 2026 | John Goll | SVP, Finance & CAO | Sell | $23K (698 @ $32.35) |
| Dec 5, 2025 | David M Berman | Head of R&D | Sell | $23K (572 @ $40.14) |
| Dec 4, 2025 | David M Berman | Head of R&D | Sell | $1.3M (31,341 @ $40.26) |
| Nov 28, 2025 | David M Berman | Head of R&D | Sell | $221K (5,521 @ $40.09) |
| Nov 26, 2025 | David M Berman | Head of R&D | Sell | $2.8M (69,404 @ $40.12) |
| Nov 25, 2025 | David M Berman | Head of R&D | Sell | $721K (18,020 @ $40.03) |
| Nov 24, 2025 | David M Berman | Head of R&D | Sell | $4K (100 @ $40.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.